Naringin Interferes Doxorubicin-Induced Myocardial Injury by Promoting the Expression of ECHS1

• Main Authors: Zirui Zhao (Author), Shilei Yang (Author), Yawen Deng (Author), Liang Wang (Author), Yifen Zhang (Author), Zhenyu Feng (Author), Han Li (Author), Zhongchao Chi (Author), Yunpeng Xie (Author), Deshi Dong (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Doxorubicin (DOX) leads to myocardial cell damage and irreversible heart failure, which limits the clinical application of DOX. Naringin has biological functions of inhibiting inflammation, oxidative stress and apoptosis. Our aim was to investigate whether Naringin could prevent DOX-related cardioto...